Arnhold LLC’s AMAG Pharmaceuticals AMAG Stock Holding History

Arnhold LLC’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,000	Closed	-$191K	–	140
2020 Q2	$191K	Hold	25,000	–	–	0.03%	132
2020 Q1	$154K	Buy	+25,000	New	+$220K	0.03%	134

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arnhold LLC's AMAG Position: Q3 2020 in Review

Arnhold LLC sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 25,000 shares — an estimated $191K sold.

Arnhold LLC first reported a position in AMAG in Q1 2020 and held it in 2 quarters. The position peaked at $191K in Q2 2020. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

Arnhold LLC reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Arnhold LLC sold 25,000 AMAG Pharmaceuticals shares in Q3 2020, an estimated $191K.
Arnhold LLC first reported a position in AMAG Pharmaceuticals in Q1 2020 and held it in 2 quarters.
Arnhold LLC's AMAG Pharmaceuticals position peaked at $191K in Q2 2020.
113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Arnhold LLC's 13F filing for Q3 2020, filed 13 Nov 2020.